Results 211 to 220 of about 40,592 (266)

Inhaled Corticosteroid-Long-Acting Beta-2 Agonist Fixed-Dose Combinations: Preferred Controller in 6- to 11-Year-Olds with Persistent Asthma.

Int Arch Allergy Immunol
Koken G, Terece SP, Akpinar CV, Ertoy Karagol HI, Bakirtas A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safety of Inhaled Corticosteroids

Proceedings of the American Thoracic Society, 2004
Abstract Systemic bioavailability from the gastrointestinal tract is reduced with newer inhaled corticosteroids (ICSs) such as fluticasone, but systemic absorption still occurs via the lung. Observational studies have shown an association between ICS use and several adverse outcomes such as cataracts, glaucoma, and adrenal failure ...
Anne E, Tattersfield, T W, Harrison, R B, Hubbard, K, Mortimer   +3 more
openaire   +2 more sources

Comparing Inhaled Corticosteroids

Respiratory Care, 2000
There are currently available 5 different inhaled corticosteroids, in a variety of different inhalation delivery devices. In the near future there will certainly be more inhaled corticosteroids in newer inhalation delivery devices available in the United States.
openaire   +2 more sources

Effects of inhaled corticosteroids on bone

Annals of Allergy, Asthma & Immunology, 2005
To discuss the effects of inhaled corticosteroids on bone and their potential public health implications.The MEDLINE and EMBASE databases were searched to identify articles published between 1966 and January 2004 with the following keywords in the title: inhaled corticosteroid, beclomethasone, budesonide, flunisolide, fluticasone, mometasone ...
K J, Mortimer, T W, Harrison, A E, Tattersfield   +2 more
openaire   +2 more sources

Comparison of Inhaled Corticosteroids

Annals of Pharmacotherapy, 1998
OBJECTIVE: To review the comparative studies evaluating both efficacy and safety of inhaled corticosteroids in the management of asthma. Specifically, comparative clinical trials are evaluated that allow clinicians to determine relative potencies of the various inhaled corticosteroids.
openaire   +2 more sources

Inhaled Corticosteroids and Mortality in COPD

Chest, 2006
To assess the influence of inhaled corticosteroids (ICSs) on mortality in COPD patients, which is currently a controversial topic.Manitoba Health maintains a population-wide research database that includes pharmaceutical information.We examined mortality in people 90 to 365 days after hospital discharge for COPD, comparing those persons who received ...
Christine, Macie, Kate, Wooldrage, Jure, Manfreda, Nicholas R, Anthonisen   +3 more
openaire   +2 more sources

Withdrawal of inhaled corticosteroids in COPD

European Respiratory Journal, 2020
ICS can be withdrawn in COPD patients without history of exacerbationshttps://bit.ly ...
James D. Chalmers, Marc Miravitlles
openaire   +2 more sources

Effects of inhaled corticosteroids on growth

Journal of Allergy and Clinical Immunology, 1998
Inhaled corticosteroids are an established treatment for asthma in childhood. The risk of adverse events associated with conventional doses of inhaled corticosteroids is low, but in children with asthma concern remains about the potential effects of these compounds on growth. Short-term growth in children can be measured with knemometry. This technique
openaire   +2 more sources

An overview of the safety of inhaled corticosteroids

International Journal of Risk & Safety in Medicine, 1994
The papers contained in this issue of the journal deal comprehensively with specific areas in which the safety of inhaled corticosteroids might give cause for concern as a result of their effects on skeletal metabolism, childhood growth, the endocrine system and the skin.
M N, Dukes, S T, Holgate, R A, Pauwels
openaire   +2 more sources